MiRNA-92a protects pancreatic B-cell function by targeting KLF2 in diabetes mellitus.

CONCLUSION: Altogether, we verified the function and mechanism of miRNA-92a and provide evidence that miRNA-92a may serve a potential candidate for the clinical treatment for DM. PMID: 29660330 [PubMed - as supplied by publisher]
Source: Biochemical and Biophysical Research communications - Category: Biochemistry Authors: Tags: Biochem Biophys Res Commun Source Type: research